BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38044812)

  • 41. Is it necessary to remove foleys catheter late after transurethral prostatectomy in patients who presented with acute urinary retention secondary to benign prostatic hyperplasia?
    Das Bhagia S; Mahmud SM; El Khalid S
    J Pak Med Assoc; 2010 Sep; 60(9):739-41. PubMed ID: 21381581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of tamsulosin and silodosin in the management of acute urinary retention secondary to benign prostatic hyperplasia in patients planned for trial without catheter. A prospective randomized study.
    Patil SB; Ranka K; Kundargi VS; Guru N
    Cent European J Urol; 2017; 70(3):259-263. PubMed ID: 29104788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention].
    Hua LX; Wu HF; Sui YG; Chen SG; Xu ZQ; Zhang W; Qian LX
    Zhonghua Nan Ke Xue; 2003 Oct; 9(7):510-1. PubMed ID: 14628599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of Duration of Catheterization on the Success Rate of Trial Without Catheter in Acute Urinary Retention Due to Benign Prostatic Enlargement.
    Ghazanfar NA; Rasheed A; Shah AA; Bhatti SA; Sohail H; Farooq A
    Cureus; 2023 Jul; 15(7):e42716. PubMed ID: 37654938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial).
    Elbendary M; El-Gamal OM; Soliman MG; Tawfik A; Taha MR
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):362-6. PubMed ID: 24018711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostatic Artery Embolization to Achieve Freedom from Catheterization in Patients with Acute Urinary Retention Caused by Benign Prostatic Hyperplasia.
    Leng B; Zhou CG; Liu S; Xu ZW; Tian W; Shi HB
    J Vasc Interv Radiol; 2021 Jul; 32(7):1062-1067. PubMed ID: 33794374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergency management of acute urinary retention: results from an all-Ireland urologist practice survey.
    Cullen IM; Dowling CM; Thornhill JA; Grainger R
    Ir J Med Sci; 2013 Jun; 182(2):207-11. PubMed ID: 23096424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of treatment with tamsulosin in men with acute urinary retention.
    Kim HL; Kim JC; Benson DA; Bales GT; Gerber GS
    Tech Urol; 2001 Dec; 7(4):256-60. PubMed ID: 11763483
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy.
    Yu SC; Cho CC; Hung EH; Chiu PK; Yee CH; Ng CF
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):33-40. PubMed ID: 27853823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.
    Roehrborn CG; Bruskewitz R; Nickel GC; Glickman S; Cox C; Anderson R; Kandzari S; Herlihy R; Kornitzer G; Brown BT; Holtgrewe HL; Taylor A; Wang D; Waldstreicher J
    Eur Urol; 2000 May; 37(5):528-36. PubMed ID: 10765090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experience of the use of silodosin in acute urinary retention caused by benign prostatic hyperplasia].
    Neĭmark AI; Nozdrachev NA
    Urologiia; 2013; (4):47-8, 50-1. PubMed ID: 24159765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patients with benign prostatic hyperplasia: A randomized clinical trial.
    Baghani Aval H; Ameli Z; Ameli M
    Urologia; 2018 May; 85(2):51-54. PubMed ID: 30043714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rezūm water vapor therapy for catheter-dependent urinary retention: a real-world Canadian experience.
    Elterman DS; Bhojani N; Vannabouathong C; Chughtai B; Zorn KC
    Can J Urol; 2022 Apr; 29(2):11075-11079. PubMed ID: 35429425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive variables of spontaneous micturition recovery after acute urinary retention in men with benign prostatic enlargement: An observational prospective study.
    Vella M; Abrate A; Costanzo A; D'Amato F; Tarantino ML; Simonato A
    Low Urin Tract Symptoms; 2019 May; 11(3):104-108. PubMed ID: 30182536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systematic review and meta-analysis on management of acute urinary retention.
    Yoon PD; Chalasani V; Woo HH
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):297-302. PubMed ID: 26195469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled.
    McNeill SA; Daruwala PD; Mitchell ID; Shearer MG; Hargreave TB
    BJU Int; 1999 Oct; 84(6):622-7. PubMed ID: 10510105
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review.
    Wong A; Mahmalji W
    Aging Male; 2020 Dec; 23(5):1620-1626. PubMed ID: 33818292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elements for Trial Without Catheter (TWOC) Success in Benign Prostatic Hyperplasia Patients: Lessons We Have Learned.
    Ivanuta M; Puia D; Pricop C
    Cureus; 2023 Dec; 15(12):e50980. PubMed ID: 38259407
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US-based insurance claims database.
    Lee S; Yoo KH; Kim TS; Cho HJ; Kim W; Oh JK; Li S; Kim SY; Wei W; Huang J; van Uem S; Del Giudice F; Lindars DP; Sathe AR; Chung BI
    Prostate; 2023 May; 83(7):722-728. PubMed ID: 36891865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.